News
& Press
INVO Bioscience Announces Pricing of $3.0 Million Registered Direct Offering Priced At-The-Market
INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on
Intchains Group Limited Announces Pricing of US$8.0 Million Initial Public Offering
Intchains Group Limited (the “Company” or “Intchains Group”), a provider of integrated solutions consisting of
SeaStar Medical Holding Corporation Closes Initial $3.3 Million Tranche of $9.8 Million Private Placement
SeaStar Medical Holding Corporation (Nasdaq: ICU) (“SeaStar Medical” or the “Company”), a medical device company
Recon Technology Announces Pricing of $8 million Registered Direct Offering
Recon Technology, Ltd. (NASDAQ: RCON) (“Recon” or the “Company”) announced today it has entered into
DIH to Become Publicly Traded via Business Combination with Aurora Technology Acquisition Corp.
DIH is a leading global robotics and virtual reality technology provider in the rehabilitation and
Nuvini and Mercato Partners Acquisition Corporation Announce Business Combination Transaction
Nuvini acquires and manages a portfolio of high growth software-as-a-service (“SaaS”) companies in Latin America. The expected
Jet Token Inc. to Become Publicly Listed via Business Combination with Oxbridge Acquisition Corp. and Change Name to Jet.AI Inc.
• Jet Token Inc. offers fractional aircraft ownership, jet card, aircraft brokerage and charter service
Unicycive Announces up to $130 Million Financing to Commercialize and Launch Investigational New Drug Renazorb
$30 million financing upfront with up to an additional $100 million tied to satisfaction of
ContraFect Announces Pricing of $10.0 Million Registered Direct Offering and Concurrent Private Placement
ContraFect (NASDAQ:CFRX) Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of
ContraFect Announces Pricing of $10.0 Million Registered Direct Offering and Concurrent Private Placement
ContraFect (NASDAQ:CFRX) Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery and development of
Performance Shipping Inc. Announces Pricing of $12.5 Million Registered Direct Offering
ATHENS, Greece, March 01, 2023 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG) (“we” or
Performance Shipping Inc. Announces Pricing of $12.5 Million Registered Direct Offering
ATHENS, Greece, March 01, 2023 (GLOBE NEWSWIRE) — Performance Shipping Inc. (NASDAQ: PSHG) (“we” or
Infobird Co., Ltd Announces Pricing of $5 Million Registered Direct Offering
BEIJING, Feb. 24, 2023 /PRNewswire/ — Infobird Co., Ltd (NASDAQ: IFBD) (“Infobird” or the “Company”), a leading and
Quoin Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company
Atlis Motor Vehicles, Inc. Announces Pricing of $13.0 Million Public Offering
Atlis Motor Vehicles, Inc. (NASDAQ: AMV) (“Atlis” or the “Company”), a vertically integrated electric vehicle
Mars Acquisition Corp. Announces Pricing of $60.0 Million Initial Public Offering
Mars Acquisition Corp. (the “Company”), a newly incorporated blank check company incorporated as a Cayman Islands exempted
TOP Ships Inc. Announces Pricing of $13.6 Million Registered Direct Offering
TOP Ships Inc. (the “Company” or “TOP Ships”) (NASDAQ:TOPS), an international owner and operator of
SeqLL Inc. Announces Pricing of $1.8 Million Registered Direct Offering
SeqLL Inc. (NASDAQ: SQL and SQLLW) (“SeqLL” or the “Company”), a technology company providing life
OceanPal Inc. Announces Pricing of Approximately US$15.2 Million Public Offering
OceanPal Inc. (NASDAQ: OP) (the “Company”), a global shipping company specializing in the ownership of
SINTX Technologies Announces Pricing of $12.0 Million Public Offering
SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), an original equipment manufacturer of advanced
Edible Garden Announces Pricing of Upsized $10.2 Million Underwritten Public Offering
Edible Garden AG Incorporated (“Edible Garden” or the “Company”) (Nasdaq: EDBL, EDBLW), a leader in
ReShape Lifesciences Announces Pricing of Upsized $10.2 Million Underwritten Public Offering
ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company,
WiSA Technologies Announces Pricing of $6.2 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market
WiSA Technologies, Inc. (NASDAQ:WISA), a developer of spatial, wireless sound technology for smart devices and
Panbela Announces Pricing of Approximately $15 Million Public Offering
Panbela Therapeutics, Inc. (Nasdaq: PBLA), (“Panbela” or the “Company”), a clinical stage company developing disruptive
